Subscribe to Newsletter

Advanced Medicine

Manufacture Advanced Medicine

Notes, Quotes, and Anecdotes: Words of Wisdom from 2023

| Rob Coker | 5 min read

A selection of some of the most poignant words spoken by interviewees this year

Manufacture Advanced Medicine

Got You Covered

| Stephanie Vine | 3 min read

From flu vaccines, to gene editing, to antibody drug conjugates, and women’s careers; we look back on our 2023 magazine covers.

Manufacture Advanced Medicine

Format and Function: Optimizing Gene Therapy Manufacturing Workflow

| Elpidia Gamez | 4 min read

Gene therapy has the potential to transform lives, but promising treatments for a wide range of diseases require optimal cell culture media solutions

Business & Regulation Quality & Compliance

The FDA Investigates T-Cell Malignancies in CAR-T Therapy

| Jamie Irvine | 4 min read

The details and reactions behind a recent FDA investigation into the cancer-risk of CAR-T therapies

Manufacture Advanced Medicine

Droplet Digital PCR Technology for Accelerated Gene Therapy Testing

| Sponsored by Bio-Rad Laboratories | 5 min read

Why drug developers are turning to this technique for rapid detection of replication-competent viruses.

Business & Regulation Standards & Regulation

The Ethical Issues of Advanced Medicine

| Sumukhi Sreevatsan | 3 min read

How do we encourage the development of new cell and gene therapies without compromising our ethics?

Manufacture Advanced Medicine

The Future Awakens

| Sponsored by Eppendorf, Millipore Sigma, Thermo Fisher Scientific & Miltenyi Biotec

Experts in the cell and gene therapy space are excited about things to come. After all, these are the pioneers of a burgeoning field of medicine.

Manufacture Facilities

Uniting a Cell and Gene Kingdom

| Jamie Irvine | 2 min read

Exploring the ins and outs of a recent UK-based collaboration between two prominent advanced medicine players

Manufacture Advanced Medicine

Reactions to the UK’s Approval of a CRISPR Medicine

| Stephanie Vine | 3 min read

Scientists celebrate a new era of genetic medicine but what do we do about the costs?

Manufacture Advanced Medicine

Putting the “Go” in Oligonucleotide Manufacturing

| Ben Pellegrini | 3 min read

Intellegens CEO Ben Pellegrini explains how machine learning is set to change the oligonucleotide manufacturing landscape

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register